Scalper1 News
Jay Luly Enanta Pharmaceuticals CEO and president 57 years old B.S., organic chemistry, University of Illinois; Ph.D., organic chemistry, University of California, Berkeley Of note: Is on the board of trustees of the Boston Biomedical Research Institute Since it went public in March, little biotech Enanta Pharmaceuticals has been in the middle of a clash between giants. Enanta (ENTA) is the developer of ABT-450, a protease inhibitor that’s one of Scalper1 News
Scalper1 News